The estimated number of visually impaired people in the world is 285 million, with 39 million blind people. About 65 percent of visually impaired people and 82 percent of all blind people are 50 years or older. Four major blinding diseases are age-re ...
On Monday scientists began a Phase 1 human clinical trial to test safety and immunogenicity, or the ability to provoke an immune response, of the Zika purified inactivated virus (ZPIV) vaccine. The study, supported by the National Institutes of ...
Beyond the critical need for securing more study volunteers across the board in clinical trials, a popular concern in all areas of clinical research is achieving inclusion in clinical trials and promoting diversity. Whether in medical journals, po ...
The pharmaceutical market in Colombia is set to rise from $5 billion in 2015 to $7.1 billion by 2020, registering a compound annual growth rate (CAGR) of 7.3%, according to research and consulting firm GlobalData. The company’s latest report state ...
FOMAT Medical is a specialist in Phase 2, 3 & Phase 4 clinical trials in South America. FOMAT is a Site Management Organization providing services that specialize in the development and management of clinical trials. We meet expectations by conc ...
The long-awaited trial comes after much preclinical cell work on more than 350 rats, 50 immunodeficient mice and 32 non-human primates. “After 20 years in the stem cell area and a daily practice of cardiac surgery, I am very cautiously optimistic,” P ...
An Iowa drug developer is preparing to test a possible Ebola vaccine in humans, as scientists race to develop ways to prevent or fight a virus that has killed more than 1,000 people in a West African outbreak. NewLink Genetics is planning an initi ...